Lv11
60 积分 2023-12-29 加入
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study
3小时前
待确认
IMscin001 Part 2: a randomised phase III, open-label, multicentre study examining the pharmacokinetics, efficacy, immunogenicity, and safety of atezolizumab subcutaneous versus intravenous administration in previously treated locally advanced or metastatic non-small-cell lung cancer and pharmacokinetics comparison with other approved indications
3小时前
已关闭
Impact of preoperative sarcopenia on postoperative complications and prognosis of gastric cancer resection: A meta-analysis of cohort studies
7天前
已完结
Cell comparative learning: A cervical cytopathology whole slide image classification method using normal and abnormal cells
27天前
已完结
Real-world comorbidities of atopic dermatitis in the US adult ambulatory population
1个月前
已完结
P3.08F.01 Interim Analysis of a Phase 2 Prospective Trial of Induction Lorlatinib in Locally Advanced ALK-Positive NSCLC (LORIN)
1个月前
已关闭
Alectinib versus crizotinib in untreated Asian patients with anaplastic lymphoma kinase-positive non-small-cell lung cancer (ALESIA): a randomised phase 3 study
1个月前
已完结
P3.08F.01 Interim Analysis of a Phase 2 Prospective Trial of Induction Lorlatinib in Locally Advanced ALK-Positive NSCLC (LORIN)
1个月前
已关闭
IPVS STATEMENT on HPV vaccination: No longer supply constraints: Towards achieving WHO vaccine targets
1个月前
已完结
Longitudinal blood immune-inflammatory and radiomic profiling to decode different patterns of acquired resistance to immunotherapy in patients with NSCLC
3个月前
已完结
皖公网安备34019202002308
